{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:11:18Z","timestamp":1773011478785,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1136\/amiajnl-2012-000930","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T04:28:35Z","timestamp":1351744115000},"page":"413-419","source":"Crossref","is-referenced-by-count":135,"title":["Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions"],"prefix":"10.1093","volume":"20","author":[{"given":"Rave","family":"Harpaz","sequence":"first","affiliation":[]},{"given":"Santiago","family":"Vilar","sequence":"additional","affiliation":[]},{"given":"William","family":"DuMouchel","sequence":"additional","affiliation":[]},{"given":"Hojjat","family":"Salmasian","sequence":"additional","affiliation":[]},{"given":"Krystl","family":"Haerian","sequence":"additional","affiliation":[]},{"given":"Nigam H","family":"Shah","sequence":"additional","affiliation":[]},{"given":"Herbert S","family":"Chase","sequence":"additional","affiliation":[]},{"given":"Carol","family":"Friedman","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2012,10,31]]},"reference":[{"key":"key\n\t\t\t\t20170522084259_R1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00228-002-0467-0","article-title":"Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study","volume":"58","author":"Schneeweiss","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170522084259_R2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522084259_R3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","article-title":"The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group","volume":"277","author":"Bates","year":"1997","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522084259_R4","unstructured":"Adverse Event Reporting System. http:\/\/www.fda.gov\/cder\/aers\/default.htm (accessed Jul 2007)."},{"key":"key\n\t\t\t\t20170522084259_R5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","article-title":"Novel statistical tools for monitoring the safety of marketed drugs","volume":"82","author":"Almenoff","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170522084259_R7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMp0905338","article-title":"The new sentinel network\u2014improving the evidence of medical-product safety","volume":"361","author":"Platt","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522084259_R8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.1926","article-title":"A basic study design for expedited safety signal evaluation based on electronic healthcare data","volume":"19","author":"Schneeweiss","year":"2010","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"key\n\t\t\t\t20170522084259_R9","doi-asserted-by":"crossref","first-page":"xxxiii","DOI":"10.1016\/S0378-6080(06)29057-3","article-title":"Data mining in drug safety: side effects of drugs essay","volume-title":"Side effects of drugs annual","author":"Hauben","year":"2007"},{"key":"key\n\t\t\t\t20170522084259_R10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","article-title":"The role of data mining in pharmacovigilance","volume":"4","author":"Hauben","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R11","doi-asserted-by":"crossref","first-page":"i73","DOI":"10.1136\/amiajnl-2011-000417","article-title":"Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis","volume":"18","author":"Vilar","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"key\n\t\t\t\t20170522084259_R12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/amiajnl-2011-000096","article-title":"Using information mining of the medical literature to improve drug safety","volume":"18","author":"Shetty","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"key\n\t\t\t\t20170522084259_R13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.drudis.2008.12.012","article-title":"Decision support methods for the detection of adverse events in post-marketing data","volume":"14","author":"Hauben","year":"2009","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170522084259_R14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","article-title":"Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002\u2014The importance of reporting suspected reactions","volume":"165","author":"Wysowski","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522084259_R15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pds.1323","article-title":"Data mining for signals in spontaneous reporting databases: proceed with caution","volume":"16","author":"Stephenson","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm0505-465","article-title":"News feature: strong medicine","volume":"11","author":"Wadman","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170522084259_R18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)70270-1","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522084259_R19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMp0905466","article-title":"Managing drug-risk information\u2014what to do with all those new numbers","volume":"361","author":"Avorn","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522084259_R20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","article-title":"Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership","volume":"153","author":"Stang","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170522084259_R21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMp078057","article-title":"Drug safety reform at the FDA\u2014pendulum swing or systematic improvement","volume":"356","author":"McClellan","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522084259_R22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/EDE.0b013e318228ca1d","article-title":"What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research","volume":"22","author":"Madigan","year":"2011","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20170522084259_R23","first-page":"S5","article-title":"Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data. Ph.D. dissertation","volume":"3","author":"Simpson","year":"2012"},{"key":"key\n\t\t\t\t20170522084259_R24","doi-asserted-by":"crossref","DOI":"10.1186\/2041-1480-3-S1-S5","article-title":"Annotation analysis for testing drug safety signals using unstructured clinical notes","author":"LePendu","year":"2012","journal-title":"J Biomed Semantics"},{"key":"key\n\t\t\t\t20170522084259_R25","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1371\/journal.pone.0000840","article-title":"The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction","volume":"2","author":"Brownstein","year":"2007","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522084259_R26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/pds.1509","article-title":"Early detection of adverse drug events within population-based health networks: application of sequential testing methods","volume":"16","author":"Brown","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R27","first-page":"1","article-title":"The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction","volume":"21","author":"Platt","year":"2012","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"key\n\t\t\t\t20170522084259_R28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/clpt.2011.83","article-title":"Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels","volume":"90","author":"Tatonetti","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170522084259_R29","doi-asserted-by":"crossref","first-page":"114ra127","DOI":"10.1126\/scitranslmed.3002774","article-title":"Predicting adverse drug events using pharmacological network models","volume":"3","author":"Cami","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170522084259_R30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yrtph.2009.01.009","article-title":"Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities","volume":"54","author":"Matthews","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"key\n\t\t\t\t20170522084259_R31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1197\/jamia.M1552","article-title":"Automated encoding of clinical documents based on natural language processing","volume":"11","author":"Friedman","year":"2004","journal-title":"J Am Med Inform Assoc"},{"key":"key\n\t\t\t\t20170522084259_R32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pds.1836","article-title":"Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?","volume":"18","author":"Trifiro","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/clpt.2009.185","article-title":"A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients","volume":"87","author":"Ramirez","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170522084259_R34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/pds.1248","article-title":"The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France","volume":"15","author":"Olivier","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522084259_R35","unstructured":"Medical Dictionary for Regulatory Activities (MedDRA). http:\/\/www.meddramsso.com\/ (accessed Jul 2012)"},{"key":"key\n\t\t\t\t20170522084259_R36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.me.33.020182.002251","article-title":"Rhabdomyolysis and Myoglobinuria","volume":"33","author":"Knochel","year":"1982","journal-title":"Ann Rev Med"},{"key":"key\n\t\t\t\t20170522084259_R37","first-page":"164","article-title":"Diagnosis and management of acute pancreatitis","volume":"62","author":"Munoz","year":"2000","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t20170522084259_R38","article-title":"Disproportionality methods for pharmacovigilance in longitudinal observational databases","author":"Zorych","year":"2011","journal-title":"Stat Methods Med Res"},{"key":"key\n\t\t\t\t20170522084259_R39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.clpt.6100233","article-title":"An evaluation of computer-aided disproportionality analysis for post-marketing signal detection","volume":"82","author":"Lehman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170522084259_R40","unstructured":"Szarfman A . Safety Data Mining. FDA Advisory Committee Meeting Briefing Document. 2006. http:\/\/www.fda.gov\/ohrms\/dockets\/as\/06\/briefing\/2006\u20134266b1\u201302-06-FDA-appendic-f.pdf (accessed Dec 2011)."},{"key":"key\n\t\t\t\t20170522084259_R41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"key\n\t\t\t\t20170522084259_R42","unstructured":"http:\/\/www.oracle.com\/us\/industries\/life-sciences\/health-sciences-empirica-signal-364243.html (accessed Jul 2012)."},{"key":"key\n\t\t\t\t20170522084259_R43","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.ehrm.2011.11.003","article-title":"Health outcomes of interest in observational data: issues in identifying definitions in the literature","volume":"3","author":"Stang","year":"2012","journal-title":"Health Outcomes Res Med"},{"key":"key\n\t\t\t\t20170522084259_R44"},{"key":"key\n\t\t\t\t20170522084259_R45","volume-title":"Modern information retrieval","author":"Baeza-Yates","year":"1999"},{"key":"key\n\t\t\t\t20170522084259_R46","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-39940-9","volume-title":"Encyclopedia of database systems","author":"Liu","year":"2009"},{"key":"key\n\t\t\t\t20170522084259_R47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03256796","article-title":"Data mining in drug safety: review of published threshold criteria for defining signals of disproportionate reporting","volume":"24","author":"Deshpande","year":"2010","journal-title":"Pharm Med"},{"key":"key\n\t\t\t\t20170522084259_R48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11096-011-9484-3","article-title":"Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia","volume":"33","author":"Bauters","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"key\n\t\t\t\t20170522084259_R49","unstructured":"Ryan P . Review of Observational Analysis Methods. White Paper. 2009. http:\/\/omop.fnih.org\/sites\/default\/files\/OMOP%20Methods%20points-to-consider%2012feb2009_post_0.pdf (accessed Jul 2012)."},{"key":"key\n\t\t\t\t20170522084259_R50","unstructured":"Observational Medical Outcomes Partnership (OMOP). http:\/\/omop.fnih.org\/ (accessed Jul 2012)."}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/20\/3\/413\/17374512\/20-3-413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T23:18:57Z","timestamp":1714519137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article-lookup\/doi\/10.1136\/amiajnl-2012-000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,31]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,10,31]]},"published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1136\/amiajnl-2012-000930","relation":{},"ISSN":["1527-974X","1067-5027"],"issn-type":[{"value":"1527-974X","type":"electronic"},{"value":"1067-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,31]]}}}